Dongdong Lu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in
-
- RNA modifications and cancer 25
- Circular RNAs in diseases 8
- Epigenetics and DNA Methylation 7
- RNA Research and Splicing 4
-
- Cancer-related molecular mechanisms research 17
- MicroRNA in disease regulation 14
- Co-authors
- Qidi Zheng (14 shared papers)Tianming Li (15 shared papers)Xin Gui (15 shared papers)Pu Hu (15 shared papers)Mengying Wu (9 shared papers)Tong Wu (5 shared papers)Haiyan Li (6 shared papers)Jiahui An (8 shared papers)
- Journals
- Oncotarget (7 papers)Journal of Cellular and Molecular Medicine (4 papers)Molecular Therapy — Nucleic Acids (3 papers)Molecular Therapy (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Dongdong Lu
46 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 1.0k
- Molecular Biology 1.2k
- Hepatology 98
- Oncology 177
- Epidemiology 192
Countries citing papers authored by Dongdong Lu
This map shows the geographic impact of Dongdong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongdong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongdong Lu more than expected).
Fields of papers citing papers by Dongdong Lu
This network shows the impact of papers produced by Dongdong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongdong Lu. The network helps show where Dongdong Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongdong Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 169 | |
| 2 | 2015 | 137 | |
| 3 | 2013 | 121 | |
| 4 | 2018 | 97 | |
| 5 | 2014 | 86 | |
| 6 | 2015 | 83 | |
| 7 | 2012 | 75 | |
| 8 | 2015 | 70 | |
| 9 | 2015 | 67 | |
| 10 | 2016 | 65 | |
| 11 | 2014 | 61 | |
| 12 | 2020 | 39 | |
| 13 | 2020 | 35 | |
| 14 | The relationship between metallothionein-1F (MT1F) gene and hepatocellular carcinoma. | 2003 | 33 |
| 15 | 2016 | 31 | |
| 16 | 2003 | 29 | |
| 17 | 2003 | 27 | |
| 18 | 2019 | 26 | |
| 19 | 2011 | 23 | |
| 20 | 2016 | 22 |
About Dongdong Lu
Dongdong Lu is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Epidemiology, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (25 papers), Cancer-related molecular mechanisms research (17 papers), MicroRNA in disease regulation (14 papers), Circular RNAs in diseases (8 papers), Epigenetics and DNA Methylation (7 papers), Cancer-related Molecular Pathways (5 papers), RNA Research and Splicing (4 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.2k citations), Hepatology (98 citations), Oncology (177 citations) and Epidemiology (192 citations). Dongdong Lu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Qidi Zheng, Tianming Li, Xin Gui, Pu Hu, Mengying Wu, Tong Wu, Haiyan Li, Jiahui An, Chang Han and Xiaoru Xin. Their work appears in journals such as Oncotarget, Journal of Cellular and Molecular Medicine, Molecular Therapy — Nucleic Acids, Molecular Therapy and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.